Seegene
Seegene Inc. is a global leader in molecular diagnostics, dedicated to making diagnostic testing more accessible, efficient, and innovative. The company develops and provides a wide range of PCR-based diagnostic solutions, including fully automated systems, advanced assays, and technologies aimed at detecting various infectious diseases and pathogens. Seegene's mission is to bring healthier and happier lives to everyone by advancing laboratory automation and syndromic testing, fostering collaborations, and contributing to global health through innovative diagnostic solutions.
Industries
Nr. of Employees
Very Large (1000+)
Patents
Detection of target nucleic acid sequences using different detection temperatures
US-12291740-B2
View DetailsModules for transferring magnetic beads, automated system comprising the same and method for nucleic acid extraction using the same
US-12188954-B2
View DetailsMethod and apparatus for detecting a plurality of target nucleic acid sequences in sample
US-12188082-B2
View Details
Detection of target nucleic acid sequences using different detection temperatures
US-12291740-B2
View DetailsModules for transferring magnetic beads, automated system comprising the same and method for nucleic acid extraction using the same
US-12188954-B2
View DetailsMethod and apparatus for detecting a plurality of target nucleic acid sequences in sample
US-12188082-B2
View DetailsProducts
Multiplex MTB detection with XDR resistance mutation panel
Multiplex real‑time PCR assay that detects Mycobacterium tuberculosis and concurrently identifies a panel of mutations associated with extensively drug‑resistant tuberculosis (including fluoroquinolone and injectable drug resistance) to support rapid diagnostic and treatment decisions.
Bacterial vaginosis multiplex real‑time PCR assay
Multiplex real‑time PCR assay for simultaneous detection and interpretation of multiple bacterial targets associated with bacterial vaginosis from genital specimens, with automated result interpretation and LIS reporting.
Candidiasis multiplex real‑time PCR assay
Multiplex real‑time PCR assay for simultaneous detection and speciation of multiple Candida species from clinical specimens with automated analysis and whole‑process controls.
HPV high‑risk genotyping multiplex PCR assay
Multiplex real‑time PCR assay for simultaneous detection and individual genotyping of multiple high‑risk HPV types, optimized for short PCR turnaround and automated workflows.
Meningitis syndromic multiplex PCR panel
Syndromic panel assays for simultaneous detection of multiple bacterial and viral pathogens associated with meningitis from cerebrospinal fluid using one‑step real‑time RT‑PCR.
Gastrointestinal viral multiplex PCR assay
Multiplex real‑time PCR assay for detection and identification of major viral causes of gastroenteritis, validated for use with automated extraction and PCR platforms for high‑throughput testing.
Multiplex MTB detection with XDR resistance mutation panel
Multiplex real‑time PCR assay that detects Mycobacterium tuberculosis and concurrently identifies a panel of mutations associated with extensively drug‑resistant tuberculosis (including fluoroquinolone and injectable drug resistance) to support rapid diagnostic and treatment decisions.
Bacterial vaginosis multiplex real‑time PCR assay
Multiplex real‑time PCR assay for simultaneous detection and interpretation of multiple bacterial targets associated with bacterial vaginosis from genital specimens, with automated result interpretation and LIS reporting.
Candidiasis multiplex real‑time PCR assay
Multiplex real‑time PCR assay for simultaneous detection and speciation of multiple Candida species from clinical specimens with automated analysis and whole‑process controls.
HPV high‑risk genotyping multiplex PCR assay
Multiplex real‑time PCR assay for simultaneous detection and individual genotyping of multiple high‑risk HPV types, optimized for short PCR turnaround and automated workflows.
Meningitis syndromic multiplex PCR panel
Syndromic panel assays for simultaneous detection of multiple bacterial and viral pathogens associated with meningitis from cerebrospinal fluid using one‑step real‑time RT‑PCR.
Gastrointestinal viral multiplex PCR assay
Multiplex real‑time PCR assay for detection and identification of major viral causes of gastroenteritis, validated for use with automated extraction and PCR platforms for high‑throughput testing.
Services
Online access to regulatory and technical documents including instructions for use, material safety data sheets and certificates of analysis to support implementation and compliance.
Online access to regulatory and technical documents including instructions for use, material safety data sheets and certificates of analysis to support implementation and compliance.
Expertise Areas
- Syndromic multiplex PCR diagnostics
- High‑multiplex real‑time PCR assay development
- Antimicrobial resistance genotyping and mutation panel detection
- Sample‑to‑result laboratory automation
Key Technologies
- Real‑time PCR (RT‑PCR)
- High‑multiplex PCR chemistry
- Single‑channel multiple Ct reporting
- One‑step real‑time RT‑PCR for RNA/DNA targets
News & Updates
Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, held the first executive roundtable with Microsoft and Springer Nature to discuss advancing its technology-sharing initiative aimed at mitigating future pandemics.
Funds and technology are being provided to innovate syndromic PCR for a healthier world, in partnership with Seegene.
Seegene Inc. announced the development of CURECA™, a next-generation system designed to streamline automation in PCR testing and laboratory environments.
Polymerase chain reaction (PCR) testing, which played a key role in tackling COVID-19, could be critical for addressing future health threats.
Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, held the first executive roundtable with Microsoft and Springer Nature to discuss advancing its technology-sharing initiative aimed at mitigating future pandemics.
Funds and technology are being provided to innovate syndromic PCR for a healthier world, in partnership with Seegene.
Seegene Inc. announced the development of CURECA™, a next-generation system designed to streamline automation in PCR testing and laboratory environments.
Polymerase chain reaction (PCR) testing, which played a key role in tackling COVID-19, could be critical for addressing future health threats.